Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Haustermans

Showing results (161-170 of 285) with videos related to

Pageof 29
Sort By:
Annals of Nuclear Medicine|September 11, 2012
Significant impact of transient deterioration of renal function on dosimetry in PRRTSofie Van Binnebeek, Kristof Baete, Christelle Terwinghe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 14, 2025
A comprehensive mechanistic study on the proton FLASH sparing effect in zebrafish embryos: From DNA damage to developmental abnormalitiesEva Bogaerts, Gaëlle Saade, Ellina Macaeva, et al.
Clinical and Translational Radiation Oncology|March 4, 2022
A year of pandemic for European particle radiotherapy: A survey on behalf of EPTN working groupAmelia Barcellini, Maurizio Massaro, Francesca Dal Mas, et al.
Plos One|June 19, 2015
DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate CancerKirill Litovkin, Aleyde Van Eynde, Steven Joniau, et al.
Urologic Oncology|February 7, 2015
Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvementLaura Van den Bergh, Evelyne Lerut, Karin Haustermans, et al.
International Journal of Radiation Oncology, Biology, Physics|December 20, 2013
Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapiesAlberto Briganti, Steven Joniau, Giorgio Gandaglia, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2019
Stereotactic body radiation therapy with optional focal lesion ablative microboost in prostate cancer: Topical review and multicenter consensusCédric Draulans, Robin De Roover, Uulke A van der Heide, et al.
BMC Cancer|July 22, 2015
TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG)Trevor Leong, B Mark Smithers, Michael Michael, et al.
Acta Oncologica (Stockholm, Sweden)|December 2, 2015
Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: Technical results, clinical outcome and factors potentially influencing survivalGeert Maleux, Christophe Deroose, Annouschka Laenen, et al.
Physics and Imaging in Radiation Oncology|October 15, 2025
Dynamic proton arc treatment planning study for oesophageal cancerMacarena Chocan Vera, Anne-Catherine Wéra, Hamdiye Ozan, et al.
Pageof 29

Showing results (161-170 of 285) with videos related to

Sort By:
Pageof 29
Annals of Nuclear Medicine|September 11, 2012
Significant impact of transient deterioration of renal function on dosimetry in PRRTSofie Van Binnebeek, Kristof Baete, Christelle Terwinghe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 14, 2025
A comprehensive mechanistic study on the proton FLASH sparing effect in zebrafish embryos: From DNA damage to developmental abnormalitiesEva Bogaerts, Gaëlle Saade, Ellina Macaeva, et al.
Clinical and Translational Radiation Oncology|March 4, 2022
A year of pandemic for European particle radiotherapy: A survey on behalf of EPTN working groupAmelia Barcellini, Maurizio Massaro, Francesca Dal Mas, et al.
Plos One|June 19, 2015
DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate CancerKirill Litovkin, Aleyde Van Eynde, Steven Joniau, et al.
Urologic Oncology|February 7, 2015
Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvementLaura Van den Bergh, Evelyne Lerut, Karin Haustermans, et al.
International Journal of Radiation Oncology, Biology, Physics|December 20, 2013
Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapiesAlberto Briganti, Steven Joniau, Giorgio Gandaglia, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 6, 2019
Stereotactic body radiation therapy with optional focal lesion ablative microboost in prostate cancer: Topical review and multicenter consensusCédric Draulans, Robin De Roover, Uulke A van der Heide, et al.
BMC Cancer|July 22, 2015
TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG)Trevor Leong, B Mark Smithers, Michael Michael, et al.
Acta Oncologica (Stockholm, Sweden)|December 2, 2015
Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: Technical results, clinical outcome and factors potentially influencing survivalGeert Maleux, Christophe Deroose, Annouschka Laenen, et al.
Physics and Imaging in Radiation Oncology|October 15, 2025
Dynamic proton arc treatment planning study for oesophageal cancerMacarena Chocan Vera, Anne-Catherine Wéra, Hamdiye Ozan, et al.
Pageof 29